Padma Islami Life Insurance Limited (DSE:PADMALIFE)
Bangladesh · Delayed Price · Currency is BDT 18.00
0.00 (0.00%)
At close: Aug 13, 2026
DSE:PADMALIFE Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 168.57 | 147.53 | 145.24 | 211.13 | 316.32 | 363.03 |
Total Interest & Dividend Income | 68.74 | 61.41 | 65.84 | 54.58 | 63.54 | 31.55 |
Gain (Loss) on Sale of Investments | 4.68 | -0.4 | -78.48 | -26.59 | 4.26 | 105.53 |
Other Revenue | 1.1 | 1.07 | 3.71 | 0.51 | 0.85 | 5.33 |
| 243.1 | 209.61 | 136.31 | 239.62 | 384.97 | 505.44 | |
Revenue Growth | 149.95% | 53.78% | -43.11% | -37.76% | -23.83% | -6.39% |
Policy Benefits | 310.54 | 328.61 | 392.53 | 251.18 | 526.66 | 337.18 |
Policy Acquisition & Underwriting Costs | 66.9 | 59.22 | 27.48 | 45.16 | 82.87 | 46.65 |
Depreciation & Amortization | 21.37 | 26.13 | 26.73 | 28.74 | 30.03 | 32.12 |
Selling, General & Administrative | 16.71 | 16.96 | 25.82 | 31.24 | 32.66 | 36.03 |
Other Operating Expenses | 0.51 | 0.83 | 1.22 | - | 5.79 | - |
Total Operating Expenses | 467.15 | 482.98 | 521.83 | 408.32 | 744.76 | 512.09 |
Operating Income | -224.05 | -273.38 | -385.53 | -168.7 | -359.78 | -6.65 |
Other Non Operating Income (Expenses) | -0.63 | -0.66 | -0.6 | 0.29 | -0.96 | -1.3 |
EBT Excluding Unusual Items | -224.69 | -274.04 | -386.13 | -168.41 | -360.75 | -7.95 |
Gain (Loss) on Sale of Assets | - | - | 3.56 | 3.33 | 1.75 | 1.18 |
Pretax Income | -224.69 | -274.04 | -382.57 | -165.08 | -359 | -6.77 |
Net Income | -224.69 | -274.04 | -382.57 | -165.08 | -359 | -6.77 |
Net Income to Common | -224.69 | -274.04 | -382.57 | -165.08 | -359 | -6.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 39 | 39 | 39 | 39 | 39 | 39 |
Shares Outstanding (Diluted) | 39 | 39 | 39 | 39 | 39 | 39 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -5.78 | -7.05 | -9.84 | -4.25 | -9.23 | -0.17 |
EPS (Diluted) | -5.78 | -7.05 | -9.84 | -4.25 | -9.23 | -0.17 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -34.38 | -23.47 | -50.35 | -141.46 | -386.79 | 376.6 |
Free Cash Flow Per Share | -0.88 | -0.60 | -1.29 | -3.64 | -9.95 | 9.69 |
Dividend Per Share | - | - | - | - | - | 0.400 |
Dividend Growth | - | - | - | - | - | - |
Operating Margin | -92.17% | -130.42% | -282.84% | -70.40% | -93.46% | -1.31% |
Profit Margin | -92.43% | -130.74% | -280.67% | -68.89% | -93.25% | -1.34% |
Free Cash Flow Margin | -14.14% | -11.20% | -36.94% | -59.04% | -100.47% | 74.51% |
EBITDA | -202.74 | -247.3 | -358.8 | -139.96 | -330.05 | 25.47 |
EBITDA Margin | -83.40% | -117.98% | -263.24% | -58.41% | -85.73% | 5.04% |
D&A For EBITDA | 21.31 | 26.07 | 26.73 | 28.74 | 29.73 | 32.12 |
EBIT | -224.05 | -273.38 | -385.53 | -168.7 | -359.78 | -6.65 |
EBIT Margin | -92.17% | -130.42% | -282.84% | -70.40% | -93.46% | -1.31% |